Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases

Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases

US Patent 7897616 · Granted Mar 1, 2011

Estimated economic value: $11,742,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination 2025
Substituted 5-fluoro-1H-pyrazolopyridines and their use2024
Substituted S-alaninate derivatives2024
Substituted 5-fluoro-1H-pyrazolopyridines and their use2022
Insulin analogs with reduced affinity to insulin receptor and use thereof2022
Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination 2021
Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucos2021
Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucos2021
Substituted 5-fluoro-1H-pyrazolopyridines and their use2020
SGC stimulators in combination with additional treatment for the therapy of cyst2019
Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibit2019
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use2018